1. Home
  2. FGMC vs AVTX Comparison

FGMC vs AVTX Comparison

Compare FGMC & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGMC
  • AVTX
  • Stock Information
  • Founded
  • FGMC 2023
  • AVTX 2011
  • Country
  • FGMC United States
  • AVTX United States
  • Employees
  • FGMC N/A
  • AVTX N/A
  • Industry
  • FGMC
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FGMC
  • AVTX Health Care
  • Exchange
  • FGMC NYSE
  • AVTX Nasdaq
  • Market Cap
  • FGMC 101.6M
  • AVTX 88.4M
  • IPO Year
  • FGMC 2025
  • AVTX 2015
  • Fundamental
  • Price
  • FGMC $9.57
  • AVTX $7.65
  • Analyst Decision
  • FGMC
  • AVTX Strong Buy
  • Analyst Count
  • FGMC 0
  • AVTX 5
  • Target Price
  • FGMC N/A
  • AVTX $36.75
  • AVG Volume (30 Days)
  • FGMC 25.8K
  • AVTX 98.4K
  • Earning Date
  • FGMC 01-01-0001
  • AVTX 03-28-2025
  • Dividend Yield
  • FGMC N/A
  • AVTX N/A
  • EPS Growth
  • FGMC N/A
  • AVTX N/A
  • EPS
  • FGMC N/A
  • AVTX N/A
  • Revenue
  • FGMC N/A
  • AVTX $820,000.00
  • Revenue This Year
  • FGMC N/A
  • AVTX N/A
  • Revenue Next Year
  • FGMC N/A
  • AVTX N/A
  • P/E Ratio
  • FGMC N/A
  • AVTX N/A
  • Revenue Growth
  • FGMC N/A
  • AVTX N/A
  • 52 Week Low
  • FGMC $4.48
  • AVTX $4.35
  • 52 Week High
  • FGMC $9.85
  • AVTX $34.46
  • Technical
  • Relative Strength Index (RSI)
  • FGMC N/A
  • AVTX 55.28
  • Support Level
  • FGMC N/A
  • AVTX $6.38
  • Resistance Level
  • FGMC N/A
  • AVTX $8.40
  • Average True Range (ATR)
  • FGMC 0.00
  • AVTX 1.10
  • MACD
  • FGMC 0.00
  • AVTX 0.12
  • Stochastic Oscillator
  • FGMC 0.00
  • AVTX 34.84

About FGMC FG MERGER II CORP

FG Merger II Corp is a blank check company.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: